Tolerance Study of Robotic-Assisted Virtual Reality Walking Rehabilitation for Non-Walking Stroke Patients
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age35-75
SponsorUniversity Hospital, Limoges
About this trial
The primary objective of this study is to evaluate the tolerance of the use of immersive virtual reality (VR) during robotic walking rehabilitation sessions by Gait Trainer (GT) in post-stroke patients.
Secondary objectives aim to evaluate the motivation to participate in VR sessions compared to conventional sessions, the participants' sense of presence within the virtual environment, and the usability of the rehabilitation device created. Finally, we will report the actual walking time and number of steps stroke patients take in VR sessions and conventional sessions.
Eligibility criteria
Qualifiers
Hemiparesis following a first ischemic or hemorrhagic stroke;
subacute phase (15 days to 6 months);
Aged 35 to 75 years;
Non-walking subject (unable to walk 3 x 10 meters without human assistance or Functional Ambulation Classification ≤ 2);
Disqualifiers
Have neurological and psychiatric conditions, other than stroke;
Conditions contraindicating the use of virtual reality (e.g., epileptic disorders, major cerebellar syndrome).
Inability to evolve in a virtual environment (MSSQ-Short > 26)
Patient with acute cardiovascular and respiratory disorders;
Trial design
Treatments tested in this trial
- GaitTrainer and Virtual Reality
Treatment groups
30 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov